Solid Biosciences Inc. (SLDB)
NASDAQ · Healthcare
Solid Biosciences Inc. Shareholder Equity 2016–2022
Solid Biosciences Inc. annual shareholder equity history from 2017 to 2022. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Solid Biosciences Inc. shareholder equity as of December 31, 2022: 211.7M, a 1.66% increase year-over-year.
- Solid Biosciences Inc. shareholder equity for 2022 were 211.7M, a 1.66% increase from 2021.
- Solid Biosciences Inc. shareholder equity for 2021 were 208.2M, a 57.63% increase from 2020.
- Solid Biosciences Inc. shareholder equity for 2020 were 132.1M, a 65.01% increase from 2019.
- Solid Biosciences Inc. shareholder equity for 2019 were 80.0M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Solid Biosciences Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2022 | $212 |
| 2021 | $208 |
| 2020 | $132 |
| 2019 | $80 |
| 2018 | $125 |
| 2017 | $-59 |
Solid Biosciences Inc. Shareholder Equity — FAQ
Solid Biosciences Inc. (SLDB) shareholder equity over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see SLDB's shareholder equity history?
The chart and table above show Solid Biosciences Inc.'s shareholder equity by year and by quarter, including the growth rate.